New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery

https://is1-ssl.mzstatic.com/image/thumb/Podcasts125/v4/47/a0/3f/47a03f03-b595-12fe-9dc3-136566910bd5/mza_9141666422414174576.jpg/600x600bb.jpg

Medical Industry Feature

ReachMD

32 episodes

3 days ago

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

Science

Medicine

RSS

All content for Medical Industry Feature is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Medical Industry Feature highlights topics brought to you by makers of products and services in the medical industry.

Science

Medicine

New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery

Medical Industry Feature

3 months ago

New 3D MRI Technology Offers Enhanced Visibility During Fibroid Surgery

Guest: Tamatha Fenster, M.D., M.S.

Tamatha Fenster, M.D., M.S., gynecologic surgeon at NewYork-Presbyterian and director of innovation and technology at The Weill Cornell Medicine Fibroid and Adenomyosis Center, explains how her team has developed a new 3D MRI technology to enhance patient outcomes in fibroid surgery. The novel software, called smartHER MRI, renders a 3D image of a patient’s uterus to more accurately identify fibroids and their precise location, which can be used for both laparoscopic and robotic surgical procedures. In a pilot study analyzing smartHER MRI vs. 2D imaging, results demonstrated that surgeons who relied on traditional imaging had residual fibroids at the 6-month follow-up, while surgeons who used smartHER MRI had no residual fibroids with their patients.